Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study.
Datta-Mannan A, Moser B, Xu W, Jackson K, Witcher J, Armstrong AW, Blauvelt A, Lio PA. Datta-Mannan A, et al. Among authors: armstrong aw. Clin Ther. 2024 Dec 4:S0149-2918(24)00323-0. doi: 10.1016/j.clinthera.2024.10.016. Online ahead of print. Clin Ther. 2024. PMID: 39638723 Free article.
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies.
Armstrong A, González-Cantero A, Khattri S, Muzy G, Malatestinic WN, Lampropoulou A, Feely M, See SK, Mert C, Blauvelt A. Armstrong A, et al. Dermatol Ther (Heidelb). 2024 Apr;14(4):933-952. doi: 10.1007/s13555-024-01136-w. Epub 2024 Mar 23. Dermatol Ther (Heidelb). 2024. PMID: 38521874 Free PMC article.
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
Blauvelt A, Gordon KB, Langley RG, Branigan PJ, Chen Y, Miller M, Han C, Fakharzadeh S, Muñoz-Elías EJ, Armstrong AW. Blauvelt A, et al. Among authors: armstrong aw. J Invest Dermatol. 2024 Dec;144(12):2816-2819.e2. doi: 10.1016/j.jid.2024.05.020. Epub 2024 Jun 25. J Invest Dermatol. 2024. PMID: 38936766 Free article. No abstract available.
Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2).
Strober B, Blauvelt A, Warren RB, Papp KA, Armstrong AW, Gordon KB, Morita A, Alexis AF, Lebwohl M, Foley P, Kisa RM, Colston E, Wang T, Banerjee S, Thaçi D. Strober B, et al. Among authors: armstrong aw. J Eur Acad Dermatol Venereol. 2024 Aug;38(8):1543-1554. doi: 10.1111/jdv.19925. Epub 2024 Mar 7. J Eur Acad Dermatol Venereol. 2024. PMID: 38451052 Clinical Trial.
An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis.
Sadrolashrafi K, Guo L, Kikuchi R, Hao A, Yamamoto RK, Tolson HC, Bilimoria SN, Yee DK, Armstrong AW. Sadrolashrafi K, et al. Among authors: armstrong aw. Cells. 2024 Mar 28;13(7):587. doi: 10.3390/cells13070587. Cells. 2024. PMID: 38607026 Free PMC article. Review.
Comorbidity Burden in Psoriasis Patients with Skin of Color.
Peterson H, Huang MY, Lee K, Kingston P, Yee D, Korouri E, Agüero R, Armstrong AW. Peterson H, et al. Among authors: armstrong aw. J Psoriasis Psoriatic Arthritis. 2024 Jan;9(1):16-22. doi: 10.1177/24755303231198482. Epub 2023 Aug 29. J Psoriasis Psoriatic Arthritis. 2024. PMID: 38516030 Free PMC article.
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis.
Pinter A, Reich A, Arenberger P, Gold LS, Armstrong A, Iversen L, Praestegaard M, Augustin M. Pinter A, et al. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2327-2335. doi: 10.1111/jdv.19330. Epub 2023 Aug 25. J Eur Acad Dermatol Venereol. 2023. PMID: 37432045 Clinical Trial.
511 results